Search

Journal Cancer communications Issue Volume 41:Issue 9(2021)

2. Bevacizumab biosimilar LY01008 compared with bevacizumab (Avastin) as first‐line treatment for Chinese patients with unresectable, metastatic, or recurrent non‐squamous non–small‐cell lung cancer: A multicenter, randomized, double‐blinded, phase III trial. Issue 9 (29th June 2021)

Authors:
Shi, Yuankai; Lei, Kaijian; Jia, Yuming; Ni, Bingqiang; He, Zhiyong; Bi, Minghong; Wang, Xicheng; Shi, Jianhua; Zhou, Ming; Sun, Qian; Wang, Guolei; Chen, Dongji; Shu, Yongqian; Liu, Lianke; Guo, Zhongliang; Liu, Yong; Yang, Junquan; Wang, Ke; Xiao, Ke; Wu, Lin
Journal:
Cancer communications
Issue:
Volume 41:Issue 9(2021)
Page Start:
889
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Front Cover: Nuclear Aurora kinase A triggers programmed death‐ligand 1‐mediated immune suppression by activating MYC transcription in triple‐negative breast cancer. Issue 9 (14th September 2021)

Authors:
Sun, Shulan; Zhou, Wei; Li, Xiaoxi; Peng, Fei; Yan, Min; Zhan, Yajing; An, Fan; Li, Xiaoyan; Liu, Yunyong; Liu, Quentin; Piao, Haozhe
Journal:
Cancer communications
Issue:
Volume 41:Issue 9(2021)
Page Start:
i
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Intra‐heterogeneity in transcription and chemoresistant property of leukemia‐initiating cells in murine Setd2−/− acute myeloid leukemia. Issue 9 (1st July 2021)

Authors:
Song, Jiachun; Du, Longting; Liu, Ping; Wang, Fuhui; Zhang, Bo; Xie, Yinyin; Lu, Jing; Jin, Yi; Zhou, Yan; Lv, Gang; Zhang, Jianmin; Chen, Saijuan; Chen, Zhu; Sun, Xiaojian; Zhang, Yuanliang; Huang, Qiuhua
Journal:
Cancer communications
Issue:
Volume 41:Issue 9(2021)
Page Start:
867
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. KDELR2 promotes breast cancer proliferation via HDAC3‐mediated cell cycle progression. Issue 9 (19th June 2021)

Authors:
Wei, Haoran; Ma, Wenhao; Lu, Xiaofei; Liu, Haiying; Lin, Kashuai; Wang, Yinghui; Ye, Zijian; Sun, Linchong; Huang, Zhitong; Pan, Tingting; Zhou, Zilong; Cheng, Eric Y.; Zhang, Huafeng; Gao, Ping; Zhong, Xiuying
Journal:
Cancer communications
Issue:
Volume 41:Issue 9(2021)
Page Start:
904
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Nuclear Aurora kinase A triggers programmed death‐ligand 1‐mediated immune suppression by activating MYC transcription in triple‐negative breast cancer. Issue 9 (12th July 2021)

Authors:
Sun, Shulan; Zhou, Wei; Li, Xiaoxi; Peng, Fei; Yan, Min; Zhan, Yajing; An, Fan; Li, Xiaoyan; Liu, Yunyong; Liu, Quentin; Piao, Haozhe
Journal:
Cancer communications
Issue:
Volume 41:Issue 9(2021)
Page Start:
851
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Outcomes and toxicities of immune checkpoint inhibitors in colorectal cancer: a real‐world retrospective analysis. Issue 9 (30th July 2021)

Authors:
Zhou, Chengjing; Jiang, Ting; Li, Rongzhen; Yuan, Yan; Xie, Weihao; Huang, Xiaoxue; Wang, Qiaoxuan; Chang, Hui; Chen, Gong; Li, Yuhong; Zeng, Zhifan; Xiao, Weiwei; Gao, Yuanhong
Journal:
Cancer communications
Issue:
Volume 41:Issue 9(2021)
Page Start:
921
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search